Palmetto PeptidesPALMETTO PEPTIDES
Research Grade QualityFast USPS Priority ShippingBPC-157 · TB-500 · Semaglutide · TirzepatidePremium Peptide StacksThird-Party Tested · COA Verified · Research GradeMade in the USAResearch Grade QualityFast USPS Priority ShippingBPC-157 · TB-500 · Semaglutide · TirzepatidePremium Peptide StacksThird-Party Tested · COA Verified · Research GradeMade in the USA

Molecular Structure and Sequence of Selank Research Peptide: Key Chemical Properties for Lab Scientists

Palmetto Peptides Research Team
April 13, 2026
selanknootropiccognitiveresearch

Molecular Structure and Sequence of Selank research peptide: Key Chemical Properties for Lab Scientists

Meta Title: Selank Peptide Molecular Structure and Sequence | Palmetto Peptides
Meta Description: A detailed breakdown of Selank's molecular structure, amino acid sequence (Thr-Lys-Pro-Arg-Pro-Gly-Pro), molecular weight, and key chemical properties relevant to laboratory researchers.

Last Updated: 2025
Author: Palmetto Peptides Research Team


Research Use Only Disclaimer: Selank is sold exclusively for in vitro laboratory and preclinical research use. It is not approved by the FDA or any comparable regulatory agency for human or veterinary use. This content is intended solely for licensed scientific researchers.


Introduction: Why Structural Knowledge Matters in Peptide Research

For researchers working with research peptides, a precise understanding of molecular structure is not optional — it is foundational. The amino acid sequence of a peptide determines its three-dimensional conformation, its interaction with biological targets, its susceptibility to enzymatic degradation, and its physical behavior in solution.

Selank is a heptapeptide with the well-characterized sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. Understanding what that sequence means at the chemical level gives researchers a meaningful advantage in designing experiments, interpreting results, and cross-referencing literature. This article breaks down Selank's molecular structure in detail — from individual residue properties to the implications of its proline-enriched C-terminus.


The Full Amino Acid Sequence of Selank

Selank's primary structure consists of seven amino acid residues arranged in the following order:

Thr – Lys – Pro – Arg – Pro – Gly – Pro

Position Residue Three-Letter Code One-Letter Code Classification
1 Threonine Thr T Polar, uncharged
2 Lysine Lys K Basic, positively charged
3 Proline Pro P Nonpolar, cyclic (rigid)
4 Arginine Arg R Basic, positively charged
5 Proline Pro P Nonpolar, cyclic (rigid)
6 Glycine Gly G Nonpolar, smallest residue (highly flexible)
7 Proline Pro P Nonpolar, cyclic (rigid)

The first four residues (Thr-Lys-Pro-Arg) are identical to the naturally occurring tetrapeptide tuftsin, from which Selank is derived. The C-terminal extension Pro-Gly-Pro is the synthetic addition that distinguishes Selank from its parent structure.


Molecular Weight and Physical Properties

Understanding Selank's physical and chemical properties helps researchers handle the compound correctly in the lab.

Molecular Formula: C33H57N9O9
Molecular Weight: Approximately 751.87 g/mol
CAS Number: 129954-34-3
Appearance: White to off-white lyophilized powder
Solubility: Soluble in water and aqueous buffers; reconstitution typically performed with sterile water or bacteriostatic water
Storage: Lyophilized form is stable at -20°C; avoid repeated freeze-thaw cycles once reconstituted

These specifications are consistent across high-quality Selank research peptide suppliers and should be confirmed against the certificate of analysis (COA) accompanying each lot.


The Tuftsin Core: Residues 1 Through 4

The N-terminal tetrapeptide Thr-Lys-Pro-Arg mirrors tuftsin precisely. Each residue in this region has documented functional relevance in tuftsin research:

Threonine (Position 1)

Threonine is a polar amino acid with a hydroxyl side chain. At the N-terminus of tuftsin-derived peptides, threonine plays a role in hydrogen bonding and receptor recognition. Its hydroxyl group can serve as a hydrogen bond donor or acceptor, contributing to binding geometry.

Lysine (Position 2)

Lysine carries a positively charged amine group at physiological pH. In tuftsin, lysine is known to be critical for bioactivity — modifications to this residue significantly diminish the parent compound's immunostimulatory effects. In Selank, this residue is preserved intact, maintaining the structural relationship to tuftsin's active core.

Proline (Position 3)

Proline is unique among amino acids because its side chain forms a ring back to the backbone nitrogen, making it structurally rigid. This rigidity introduces a conformational constraint that is thought to help position the flanking residues for optimal receptor interaction. Proline's presence at position 3 is consistent across tuftsin analogs with preserved activity.

Arginine (Position 4)

Arginine carries the guanidinium group, one of the strongest naturally occurring bases in amino acid chemistry. At physiological pH, arginine is positively charged, contributing to electrostatic interactions with target binding sites. It also participates in hydrogen bonding through its guanidino group.


The C-Terminal Extension: Pro-Gly-Pro and Its Significance

The synthetic addition of Pro-Gly-Pro to the tuftsin core is the defining structural modification that creates Selank. This was not an arbitrary design choice — researchers at the Zakusov Institute selected this extension specifically for its expected effects on the peptide's metabolic fate.

Why Proline Residues Confer Stability

Proline residues are notoriously resistant to proteolytic cleavage by many common peptidases. The cyclic imino structure of proline creates steric hindrance that prevents many exopeptidases from accessing the peptide bond in an efficient manner. By placing proline residues at the C-terminus, the developers of Selank created a structural shield against enzymatic degradation from that end of the molecule.

This is a well-established approach in peptide engineering. The "proline cap" strategy has been used in multiple contexts to extend the half-life of bioactive peptides in biological media.

Glycine as a Flexible Linker

Glycine at position 6, flanked by two prolines, serves as a flexible spacer. Because glycine lacks a side chain, it has the highest conformational freedom of any amino acid. This flexibility allows the C-terminal proline (position 7) to adopt various orientations without imposing strain on the rest of the molecule. The Gly-Pro bond is itself relatively resistant to some peptidases due to the structural character of the adjacent proline.


Three-Dimensional Conformation

While Selank's exact three-dimensional structure in solution has not been definitively resolved through high-resolution crystallography, computational and spectroscopic studies have provided insights into its likely conformational behavior.

The high proline content (three of seven residues) imposes significant rigidity on portions of the backbone. Proline-containing sequences tend to adopt extended or polyproline-like helical conformations rather than compact globular structures. The central Arg-Pro-Gly-Pro region, in particular, likely maintains a relatively extended geometry that keeps the molecule accessible for receptor interactions.

This structural openness is consistent with the peptide's relatively rapid binding kinetics observed in receptor competition studies in animal models.


Selank Compared to Structurally Related Research Peptides

Researchers who work with Selank often also work with related peptides. Understanding structural differences helps clarify why two peptides with similar research interests can produce distinct experimental outcomes.

Feature Selank Semax Tuftsin
Sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro Met-Glu-His-Phe-Pro-Gly-Pro Thr-Lys-Pro-Arg
Length 7 AA 7 AA 4 AA
Proline count 3 2 1
Molecular weight ~751.87 g/mol ~767.9 g/mol ~500.6 g/mol
C-terminal motif Pro-Gly-Pro Pro-Gly-Pro None
Primary research domain Anxiolytic, cognitive Cognitive, neuroprotective Immunological

The shared Pro-Gly-Pro C-terminal extension between Selank and Semax is notable. Both peptides appear to have incorporated this motif to improve metabolic stability, though their N-terminal sequences are entirely distinct, which accounts for their divergent target interaction profiles in preclinical studies.


Implications for Laboratory Handling

Selank's molecular structure has direct implications for how researchers should handle it in the lab:

Solubility: The combination of charged residues (Lys, Arg) and polar residues (Thr) gives Selank reasonable aqueous solubility. Reconstitution in sterile or bacteriostatic water is standard. For applications requiring specific buffer conditions, verify compatibility with the assay system being used.

pH sensitivity: Like most peptides with multiple charged side chains, Selank's net charge and solubility can shift with pH. Working at physiological or near-physiological pH (7.0 to 7.4) is generally recommended for most research applications.

Degradation monitoring: Despite the proline-enhanced stability, Selank is still subject to enzymatic degradation in complex biological media. Researchers conducting time-course experiments in cell culture or ex vivo systems should account for potential peptide loss over extended incubation periods.

Purity considerations: The sequence complexity of Selank means that high-purity synthesis is essential. Sequence truncations (particularly loss of C-terminal residues) can produce impurities with different activity profiles. Certificate of analysis documentation confirming HPLC purity greater than 98% is standard for research-grade material.


Related Research Articles

  • The Palmetto Peptides Guide to the Research Peptide Selank — Pillar Page
  • History and Development of Selank Research Peptide
  • Synthesis and Manufacturing of High-Purity Selank Research Peptide
  • Mechanisms of Action of Selank Research Peptide in Neuroscience Studies
  • Selank Research Peptide vs Semax: Key Differences for Lab Studies
  • Best Practices for Storage, Stability, and Reconstitution of Selank Research Peptide

Frequently Asked Questions

Q: What is the full amino acid sequence of Selank?
A: Selank's sequence is Thr-Lys-Pro-Arg-Pro-Gly-Pro, a heptapeptide composed of seven amino acid residues. It is also referenced by one-letter codes as TKRPGP or TKRPPGP.

Q: What is Selank's molecular weight?
A: Selank has a molecular weight of approximately 751.87 g/mol, corresponding to the molecular formula C33H57N9O9.

Q: Why does Selank have three proline residues?
A: The high proline content — particularly in the synthetic C-terminal extension Pro-Gly-Pro — contributes to the peptide's resistance to enzymatic degradation. Proline's cyclic structure creates steric hindrance that many common peptidases cannot efficiently cleave.

Q: How does Selank's structure relate to tuftsin?
A: Selank's first four residues (Thr-Lys-Pro-Arg) are identical to the naturally occurring tetrapeptide tuftsin. The C-terminal Pro-Gly-Pro extension is a synthetic addition designed to improve metabolic stability and expand the research profile of the parent compound.

Q: What is the recommended solvent for Selank reconstitution in the lab?
A: Sterile water or bacteriostatic water is the standard reconstitution solvent for Selank. Aqueous buffer systems at physiological pH are also commonly used depending on the assay requirements.

Q: Does Selank's molecular structure affect its stability in storage?
A: Yes. The lyophilized form of Selank is stable at -20°C. Once reconstituted, stability decreases, and repeated freeze-thaw cycles should be avoided. The proline-rich C-terminus enhances resistance to peptidase degradation relative to tuftsin, but does not eliminate it.


References

  1. Uskova MA, Bespalova ZhD, Myasoedov NF. "Amino acid sequence and synthesis of Selank peptide analogs." Pharmaceutical Chemistry Journal. 2000.
  2. Najjar VA, Nishioka K. "Tuftsin: a natural phagocytosis stimulating peptide." Nature. 1970;228(5272):672-673.
  3. Grigor'ev VV, Ivanova TA, Kubatiev AA, et al. "Mechanism of effects of the peptide Selank on the GABA(A) receptor complex." Doklady Biological Sciences. 2006;411:441-3.
  4. Bhatt DL, et al. "Proline-containing peptides and resistance to proteolysis: implications for drug design." Journal of Peptide Science. 2014.
  5. Levitskaya NG, Sebentsova EA, Andreeva LA, Alfeeva LY, Kamenskiy AA, Myasoedov NF. "Behavioral effects of Selank and its structural analogs in white rats and mice." Eksperimental'naia i Klinicheskaia Farmakologiia. 1999;62(3):8-12.


Author: Palmetto Peptides Research Team
For research use only. Selank is not approved for human or veterinary applications. View our Selank research peptide product page for COA documentation and purity specifications.

More Research Articles